APO Research
Talk to an analyst

APO RESEARCH · REPORT

Encorafenib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Encorafenib Market Analysis and Forecast 2026-2032

23 December 2025193 pages

Choose your research edition.

Industry ResearchEncorafenib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Encorafenib Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Encorafenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Encorafenib Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Encorafenib Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Encorafenib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Encorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Encorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Encorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Encorafenib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Encorafenib include Array BioPharma. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Encorafenib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Encorafenib, also provides the sales of main regions and countries. Of the upcoming market potential for Encorafenib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Encorafenib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Encorafenib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Encorafenib sales, projected growth trends, production technology, application and end-user industry.

Encorafenib Segment by Company

Array BioPharma

Encorafenib Segment by Type

50mg Capsules

75mg Capsules

Encorafenib Segment by Application

Clinic

Hospital

Pharmacy

Others

Encorafenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Encorafenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Encorafenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Encorafenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Encorafenib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Encorafenib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Encorafenib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Encorafenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg Capsules Major Manufacturers Table 3. 75mg Capsules Major Manufacturers Table 4. Global Encorafenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Others Major Manufacturers Table 9. Encorafenib Industry Trends Table 10. Encorafenib Industry Drivers Table 11. Encorafenib Industry Opportunities and Challenges Table 12. Encorafenib Industry Restraints Table 13. Global Encorafenib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Encorafenib Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Encorafenib Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Encorafenib Revenue Market Share by Region (2021-2026) Table 17. Global Encorafenib Revenue Market Share by Region (2027-2032) Table 18. Global Encorafenib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Encorafenib Sales by Region (2021-2026) & (k units) Table 20. Global Encorafenib Sales by Region (2027-2032) & (k units) Table 21. Global Encorafenib Sales Market Share by Region (2021-2026) Table 22. Global Encorafenib Sales Market Share by Region (2027-2032) Table 23. Global Encorafenib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Encorafenib Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Encorafenib Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Encorafenib Sales Market Share by Manufacturers (2021-2026) Table 27. Global Encorafenib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Encorafenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Encorafenib Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Encorafenib Manufacturers, Product Type & Application Table 31. Global Encorafenib Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Encorafenib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Encorafenib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Encorafenib Revenue Market Share by Type (2021-2026) Table 38. Global Encorafenib Revenue Market Share by Type (2027-2032) Table 39. Global Encorafenib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Encorafenib Sales by Type (2021-2026) & (k units) Table 41. Global Encorafenib Sales by Type (2027-2032) & (k units) Table 42. Global Encorafenib Sales Market Share by Type (2021-2026) Table 43. Global Encorafenib Sales Market Share by Type (2027-2032) Table 44. Global Encorafenib Price by Type (2021-2026) & (US$/unit) Table 45. Global Encorafenib Price by Type (2027-2032) & (US$/unit) Table 46. Global Encorafenib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Encorafenib Revenue Market Share by Application (2021-2026) Table 50. Global Encorafenib Revenue Market Share by Application (2027-2032) Table 51. Global Encorafenib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Encorafenib Sales by Application (2021-2026) & (k units) Table 53. Global Encorafenib Sales by Application (2027-2032) & (k units) Table 54. Global Encorafenib Sales Market Share by Application (2021-2026) Table 55. Global Encorafenib Sales Market Share by Application (2027-2032) Table 56. Global Encorafenib Price by Application (2021-2026) & (US$/unit) Table 57. Global Encorafenib Price by Application (2027-2032) & (US$/unit) Table 58. Array BioPharma Company Information Table 59. Array BioPharma Business Overview Table 60. Array BioPharma Encorafenib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Array BioPharma Encorafenib Product Portfolio Table 62. Array BioPharma Recent Development Table 63. North America Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Encorafenib Sales by Type (2021-2026) & (k units) Table 66. North America Encorafenib Sales by Type (2027-2032) & (k units) Table 67. North America Encorafenib Sales Price by Type (2021-2026) & (US$/unit) Table 68. North America Encorafenib Sales Price by Type (2027-2032) & (US$/unit) Table 69. North America Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Encorafenib Sales by Application (2021-2026) & (k units) Table 72. North America Encorafenib Sales by Application (2027-2032) & (k units) Table 73. North America Encorafenib Sales Price by Application (2021-2026) & (US$/unit) Table 74. North America Encorafenib Sales Price by Application (2027-2032) & (US$/unit) Table 75. North America Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Encorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Encorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Encorafenib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 79. North America Encorafenib Sales by Country (2021-2026) & (k units) Table 80. North America Encorafenib Sales by Country (2027-2032) & (k units) Table 81. North America Encorafenib Sales Price by Country (2021-2026) & (US$/unit) Table 82. North America Encorafenib Sales Price by Country (2027-2032) & (US$/unit) Table 83. United States Encorafenib Revenue (2021-2032) & (US$ Million) Table 84. Canada Encorafenib Revenue (2021-2032) & (US$ Million) Table 85. Mexico Encorafenib Revenue (2021-2032) & (US$ Million) Table 86. Europe Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Encorafenib Sales by Type (2021-2026) & (k units) Table 89. Europe Encorafenib Sales by Type (2027-2032) & (k units) Table 90. Europe Encorafenib Sales Price by Type (2021-2026) & (US$/unit) Table 91. Europe Encorafenib Sales Price by Type (2027-2032) & (US$/unit) Table 92. Europe Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Encorafenib Sales by Application (2021-2026) & (k units) Table 95. Europe Encorafenib Sales by Application (2027-2032) & (k units) Table 96. Europe Encorafenib Sales Price by Application (2021-2026) & (US$/unit) Table 97. Europe Encorafenib Sales Price by Application (2027-2032) & (US$/unit) Table 98. Europe Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Encorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Encorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Encorafenib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 102. Europe Encorafenib Sales by Country (2021-2026) & (k units) Table 103. Europe Encorafenib Sales by Country (2027-2032) & (k units) Table 104. Europe Encorafenib Sales Price by Country (2021-2026) & (US$/unit) Table 105. Europe Encorafenib Sales Price by Country (2027-2032) & (US$/unit) Table 106. Germany Encorafenib Revenue (2021-2032) & (US$ Million) Table 107. France Encorafenib Revenue (2021-2032) & (US$ Million) Table 108. U.K. Encorafenib Revenue (2021-2032) & (US$ Million) Table 109. Italy Encorafenib Revenue (2021-2032) & (US$ Million) Table 110. Russia Encorafenib Revenue (2021-2032) & (US$ Million) Table 111. Spain Encorafenib Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Encorafenib Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Encorafenib Revenue (2021-2032) & (US$ Million) Table 114. Sweden Encorafenib Revenue (2021-2032) & (US$ Million) Table 115. Poland Encorafenib Revenue (2021-2032) & (US$ Million) Table 116. China Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 117. China Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 118. China Encorafenib Sales by Type (2021-2026) & (k units) Table 119. China Encorafenib Sales by Type (2027-2032) & (k units) Table 120. China Encorafenib Sales Price by Type (2021-2026) & (US$/unit) Table 121. China Encorafenib Sales Price by Type (2027-2032) & (US$/unit) Table 122. China Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 123. China Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 124. China Encorafenib Sales by Application (2021-2026) & (k units) Table 125. China Encorafenib Sales by Application (2027-2032) & (k units) Table 126. China Encorafenib Sales Price by Application (2021-2026) & (US$/unit) Table 127. China Encorafenib Sales Price by Application (2027-2032) & (US$/unit) Table 128. Asia Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Encorafenib Sales by Type (2021-2026) & (k units) Table 131. Asia Encorafenib Sales by Type (2027-2032) & (k units) Table 132. Asia Encorafenib Sales Price by Type (2021-2026) & (US$/unit) Table 133. Asia Encorafenib Sales Price by Type (2027-2032) & (US$/unit) Table 134. Asia Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Encorafenib Sales by Application (2021-2026) & (k units) Table 137. Asia Encorafenib Sales by Application (2027-2032) & (k units) Table 138. Asia Encorafenib Sales Price by Application (2021-2026) & (US$/unit) Table 139. Asia Encorafenib Sales Price by Application (2027-2032) & (US$/unit) Table 140. Asia Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Encorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Encorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Encorafenib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Asia Encorafenib Sales by Country (2021-2026) & (k units) Table 145. Asia Encorafenib Sales by Country (2027-2032) & (k units) Table 146. Asia Encorafenib Sales Price by Country (2021-2026) & (US$/unit) Table 147. Asia Encorafenib Sales Price by Country (2027-2032) & (US$/unit) Table 148. Japan Encorafenib Revenue (2021-2032) & (US$ Million) Table 149. South Korea Encorafenib Revenue (2021-2032) & (US$ Million) Table 150. India Encorafenib Revenue (2021-2032) & (US$ Million) Table 151. Australia Encorafenib Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Encorafenib Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Encorafenib Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Encorafenib Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Encorafenib Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Encorafenib Sales by Type (2021-2026) & (k units) Table 157. SAMEA Encorafenib Sales by Type (2027-2032) & (k units) Table 158. SAMEA Encorafenib Sales Price by Type (2021-2026) & (US$/unit) Table 159. SAMEA Encorafenib Sales Price by Type (2027-2032) & (US$/unit) Table 160. SAMEA Encorafenib Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Encorafenib Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Encorafenib Sales by Application (2021-2026) & (k units) Table 163. SAMEA Encorafenib Sales by Application (2027-2032) & (k units) Table 164. SAMEA Encorafenib Sales Price by Application (2021-2026) & (US$/unit) Table 165. SAMEA Encorafenib Sales Price by Application (2027-2032) & (US$/unit) Table 166. SAMEA Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Encorafenib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Encorafenib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Encorafenib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. SAMEA Encorafenib Sales by Country (2021-2026) & (k units) Table 171. SAMEA Encorafenib Sales by Country (2027-2032) & (k units) Table 172. SAMEA Encorafenib Sales Price by Country (2021-2026) & (US$/unit) Table 173. SAMEA Encorafenib Sales Price by Country (2027-2032) & (US$/unit) Table 174. Brazil Encorafenib Revenue (2021-2032) & (US$ Million) Table 175. Argentina Encorafenib Revenue (2021-2032) & (US$ Million) Table 176. Chile Encorafenib Revenue (2021-2032) & (US$ Million) Table 177. Colombia Encorafenib Revenue (2021-2032) & (US$ Million) Table 178. Peru Encorafenib Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Encorafenib Revenue (2021-2032) & (US$ Million) Table 180. Israel Encorafenib Revenue (2021-2032) & (US$ Million) Table 181. UAE Encorafenib Revenue (2021-2032) & (US$ Million) Table 182. Turkey Encorafenib Revenue (2021-2032) & (US$ Million) Table 183. Iran Encorafenib Revenue (2021-2032) & (US$ Million) Table 184. Egypt Encorafenib Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Encorafenib Distributors List Table 188. Encorafenib Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Encorafenib Image Figure 2. Global Encorafenib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Encorafenib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg Capsules Image Figure 5. 75mg Capsules Image Figure 6. Global Encorafenib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Encorafenib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Others Image Figure 12. Global Encorafenib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Encorafenib Revenue (2021-2032) & (US$ Million) Figure 14. Global Encorafenib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Encorafenib Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Encorafenib Revenue Market Share by Region (2021-2032) Figure 17. Global Encorafenib Sales (2021-2032) & (k units) Figure 18. Global Encorafenib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Encorafenib Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Encorafenib Sales YoY (2021-2032) & (k units) Figure 21. Europe Encorafenib Sales YoY (2021-2032) & (k units) Figure 22. China Encorafenib Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Encorafenib Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Encorafenib Sales YoY (2021-2032) & (k units) Figure 25. Global Encorafenib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Encorafenib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Encorafenib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Encorafenib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Encorafenib Revenue Market Share by Type (2021-2032) Figure 31. Global Encorafenib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Encorafenib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Encorafenib Sales Market Share by Type (2021-2032) Figure 34. Global Encorafenib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Encorafenib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Encorafenib Revenue Market Share by Application (2021-2032) Figure 37. Global Encorafenib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Encorafenib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Encorafenib Sales Market Share by Application (2021-2032) Figure 40. North America Encorafenib Revenue Share by Type (2021-2032) Figure 41. North America Encorafenib Sales Share by Type (2021-2032) Figure 42. North America Encorafenib Revenue Share by Application (2021-2032) Figure 43. North America Encorafenib Sales Share by Application (2021-2032) Figure 44. North America Encorafenib Revenue Share by Country (2021-2032) Figure 45. North America Encorafenib Sales Share by Country (2021-2032) Figure 46. Europe Encorafenib Revenue Share by Type (2021-2032) Figure 47. Europe Encorafenib Sales Share by Type (2021-2032) Figure 48. Europe Encorafenib Revenue Share by Application (2021-2032) Figure 49. Europe Encorafenib Sales Share by Application (2021-2032) Figure 50. Europe Encorafenib Revenue Share by Country (2021-2032) Figure 51. Europe Encorafenib Sales Share by Country (2021-2032) Figure 52. China Encorafenib Revenue Share by Type (2021-2032) Figure 53. China Encorafenib Sales Share by Type (2021-2032) Figure 54. China Encorafenib Revenue Share by Application (2021-2032) Figure 55. China Encorafenib Sales Share by Application (2021-2032) Figure 56. Asia Encorafenib Revenue Share by Type (2021-2032) Figure 57. Asia Encorafenib Sales Share by Type (2021-2032) Figure 58. Asia Encorafenib Revenue Share by Application (2021-2032) Figure 59. Asia Encorafenib Sales Share by Application (2021-2032) Figure 60. Asia Encorafenib Revenue Share by Country (2021-2032) Figure 61. Asia Encorafenib Sales Share by Country (2021-2032) Figure 62. SAMEA Encorafenib Revenue Share by Type (2021-2032) Figure 63. SAMEA Encorafenib Sales Share by Type (2021-2032) Figure 64. SAMEA Encorafenib Revenue Share by Application (2021-2032) Figure 65. SAMEA Encorafenib Sales Share by Application (2021-2032) Figure 66. SAMEA Encorafenib Revenue Share by Country (2021-2032) Figure 67. SAMEA Encorafenib Sales Share by Country (2021-2032) Figure 68. Encorafenib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Encorafenib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg Capsules
  • 75mg Capsules
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Array BioPharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Encorafenib Market by Type
  3. 1.2.1 Global Encorafenib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg Capsules
  5. 1.2.3 75mg Capsules
  6. 1.3 Encorafenib Market by Application
  7. 1.3.1 Global Encorafenib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Pharmacy
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Encorafenib Market Dynamics
  1. 2.1 Encorafenib Industry Trends
  2. 2.2 Encorafenib Industry Drivers
  3. 2.3 Encorafenib Industry Opportunities and Challenges
  4. 2.4 Encorafenib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Encorafenib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Encorafenib Revenue by Region
  3. 3.2.1 Global Encorafenib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Encorafenib Revenue by Region (2021-2026)
  5. 3.2.3 Global Encorafenib Revenue by Region (2027-2032)
  6. 3.2.4 Global Encorafenib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Encorafenib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Encorafenib Sales by Region
  9. 3.4.1 Global Encorafenib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Encorafenib Sales by Region (2021-2026)
  11. 3.4.3 Global Encorafenib Sales by Region (2027-2032)
  12. 3.4.4 Global Encorafenib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Encorafenib Revenue by Manufacturers
  2. 4.1.1 Global Encorafenib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Encorafenib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Encorafenib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Encorafenib Sales by Manufacturers
  6. 4.2.1 Global Encorafenib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Encorafenib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Encorafenib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Encorafenib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Encorafenib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Encorafenib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Encorafenib Manufacturers, Product Type & Application
  13. 4.7 Global Encorafenib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Encorafenib Market CR5 and HHI
  16. 4.8.2 2025 Encorafenib Tier 1, Tier 2, and Tier 3
5 Encorafenib Market by Type
  1. 5.1 Global Encorafenib Revenue by Type
  2. 5.1.1 Global Encorafenib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Encorafenib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Encorafenib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Encorafenib Sales by Type
  6. 5.2.1 Global Encorafenib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Encorafenib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Encorafenib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Encorafenib Price by Type
6 Encorafenib Market by Application
  1. 6.1 Global Encorafenib Revenue by Application
  2. 6.1.1 Global Encorafenib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Encorafenib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Encorafenib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Encorafenib Sales by Application
  6. 6.2.1 Global Encorafenib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Encorafenib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Encorafenib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Encorafenib Price by Application
7 Company Profiles
  1. 7.1 Array BioPharma
  2. 7.1.1 Array BioPharma Company Information
  3. 7.1.2 Array BioPharma Business Overview
  4. 7.1.3 Array BioPharma Encorafenib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Array BioPharma Encorafenib Product Portfolio
  6. 7.1.5 Array BioPharma Recent Developments
8 North America
  1. 8.1 North America Encorafenib Market Size by Type
  2. 8.1.1 North America Encorafenib Revenue by Type (2021-2032)
  3. 8.1.2 North America Encorafenib Sales by Type (2021-2032)
  4. 8.1.3 North America Encorafenib Price by Type (2021-2032)
  5. 8.2 North America Encorafenib Market Size by Application
  6. 8.2.1 North America Encorafenib Revenue by Application (2021-2032)
  7. 8.2.2 North America Encorafenib Sales by Application (2021-2032)
  8. 8.2.3 North America Encorafenib Price by Application (2021-2032)
  9. 8.3 North America Encorafenib Market Size by Country
  10. 8.3.1 North America Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Encorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Encorafenib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Encorafenib Market Size by Type
  2. 9.1.1 Europe Encorafenib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Encorafenib Sales by Type (2021-2032)
  4. 9.1.3 Europe Encorafenib Price by Type (2021-2032)
  5. 9.2 Europe Encorafenib Market Size by Application
  6. 9.2.1 Europe Encorafenib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Encorafenib Sales by Application (2021-2032)
  8. 9.2.3 Europe Encorafenib Price by Application (2021-2032)
  9. 9.3 Europe Encorafenib Market Size by Country
  10. 9.3.1 Europe Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Encorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Encorafenib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Encorafenib Market Size by Type
  2. 10.1.1 China Encorafenib Revenue by Type (2021-2032)
  3. 10.1.2 China Encorafenib Sales by Type (2021-2032)
  4. 10.1.3 China Encorafenib Price by Type (2021-2032)
  5. 10.2 China Encorafenib Market Size by Application
  6. 10.2.1 China Encorafenib Revenue by Application (2021-2032)
  7. 10.2.2 China Encorafenib Sales by Application (2021-2032)
  8. 10.2.3 China Encorafenib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Encorafenib Market Size by Type
  2. 11.1.1 Asia Encorafenib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Encorafenib Sales by Type (2021-2032)
  4. 11.1.3 Asia Encorafenib Price by Type (2021-2032)
  5. 11.2 Asia Encorafenib Market Size by Application
  6. 11.2.1 Asia Encorafenib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Encorafenib Sales by Application (2021-2032)
  8. 11.2.3 Asia Encorafenib Price by Application (2021-2032)
  9. 11.3 Asia Encorafenib Market Size by Country
  10. 11.3.1 Asia Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Encorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Encorafenib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Encorafenib Market Size by Type
  2. 12.1.1 SAMEA Encorafenib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Encorafenib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Encorafenib Price by Type (2021-2032)
  5. 12.2 SAMEA Encorafenib Market Size by Application
  6. 12.2.1 SAMEA Encorafenib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Encorafenib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Encorafenib Price by Application (2021-2032)
  9. 12.3 SAMEA Encorafenib Market Size by Country
  10. 12.3.1 SAMEA Encorafenib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Encorafenib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Encorafenib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Encorafenib Value Chain Analysis
  2. 13.1.1 Encorafenib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Encorafenib Production Mode & Process
  6. 13.2 Encorafenib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Encorafenib Distributors
  9. 13.2.3 Encorafenib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst